These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2875985)
1. New perspectives in cardiology: recent advances in antiarrhythmic drug therapy. Novotny MJ; Adams HR J Am Vet Med Assoc; 1986 Sep; 189(5):533-9. PubMed ID: 2875985 [TBL] [Abstract][Full Text] [Related]
2. New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs. Adams HR J Am Vet Med Assoc; 1986 Sep; 189(5):525-32. PubMed ID: 2875984 [TBL] [Abstract][Full Text] [Related]
3. New drugs for treatment of ventricular arrhythmias. Heger JJ; Prystowsky EN; Zipes DP Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255 [TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic drug therapy: new drugs and changing concepts. Reiser HJ; Sullivan ME Fed Proc; 1986 Jul; 45(8):2206-12. PubMed ID: 2873062 [TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic drug therapy for sustained ventricular tachycardia. Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202 [TBL] [Abstract][Full Text] [Related]
6. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances. Pratt CM; Luck JC; Mann DE; Wyndham CR Cardiol Clin; 1984 Feb; 2(1):35-46. PubMed ID: 6443563 [TBL] [Abstract][Full Text] [Related]
7. New drugs in the management of ventricular arrhythmias. Sanna GP G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894 [TBL] [Abstract][Full Text] [Related]
12. Current clinical perspectives on antiarrhythmic drug therapy. Anderson JL Fed Proc; 1986 Jul; 45(8):2213-9. PubMed ID: 3720963 [TBL] [Abstract][Full Text] [Related]
13. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331 [TBL] [Abstract][Full Text] [Related]
14. The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias. Cain ME Angiology; 1988 Jul; 39(7 Pt 2):668-83. PubMed ID: 3044200 [TBL] [Abstract][Full Text] [Related]
15. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms. Masotti CS; Pierangeli A Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709 [TBL] [Abstract][Full Text] [Related]
18. [Possibilities and limitations of treatment for arrhythmia]. Lüderitz B Z Gesamte Inn Med; 1991 Aug; 46(12):425-30. PubMed ID: 1950023 [TBL] [Abstract][Full Text] [Related]
19. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy. Anderson JL Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II. Singh BN; Cho YW; Kuemmerle HP Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721 [No Abstract] [Full Text] [Related] [Next] [New Search]